Written by Ad OpsIntroduction to Zero Gravity (CBD)
Zero Gravity (CBD) is a CBD-forward cultivar developed to deliver functional calm with minimal intoxication. As the name hints, its signature experience is weightless clarity, a soft deceleration of stress without the heavy couchlock often associated with high-THC varieties. This profile focuses specifically on the CBD-dominant version of Zero Gravity, which is distinct from similarly named THC-dominant strains in the market.
Consumers gravitate to this chemotype for daytime usability and repeatable effects. It is commonly selected by people seeking focus, social ease, or post-exercise recovery with a low risk of impairment. The strain’s approachable flavor, typically led by gentle pine and sweet herbal notes, adds to its accessibility for new and experienced users alike.
Because CBD cultivars can vary by breeder and region, Zero Gravity (CBD) should always be verified by a current certificate of analysis before purchase. Labels may advertise a CBD:THC ratio, but real-world lab data is the only reliable indicator of potency. In practice, this cultivar tends to express strong CBD dominance, most often landing in double-digit CBD percentages with sub-psychoactive THC.
History and Market Context
The rise of CBD-focused cultivars traces back to the early 2010s, when patient demand and early clinical milestones pushed high-CBD cannabis into the spotlight. Landmark moments included the growing public attention around pediatric epilepsy and purified CBD, culminating in the FDA approval of a cannabidiol oral solution in 2018. Parallel to these developments, breeders began curating stable high-CBD lines that could thrive in both hemp and cannabis regulatory frameworks.
By 2018–2020, the broader CBD market expanded rapidly, with industry estimates suggesting U.S. CBD product sales crossing USD 4–5 billion annually. Flower-specific sales grew alongside oils and edibles, as consumers sought terpene-rich whole-plant experiences with predictable potency. In this context, cultivars like Zero Gravity (CBD) emerged as consumer-friendly options emphasizing clarity, low anxiety, and consistent functional relief.
Zero Gravity (CBD) appears to have been selected and multiplied by multiple craft producers rather than originating from a single globally dominant breeder. The name suits its effect profile and has likely been used for both CBD-dominant and THC-dominant lines, creating occasional naming confusion. As a result, market best practice now emphasizes verifying cannabinoid content via COAs rather than relying solely on cultivar names.
Within dispensaries and craft hemp shops, CBD-dominant flower typically accounts for a modest but stable share of the shelf, often 5–15% of dried flower SKUs in mixed-THC markets. In strictly hemp markets, CBD flower can account for the majority of shelf space, with cultivars like Zero Gravity (CBD) positioned as a premium tier due to flavor and terpene expression. Over time, the strain has gained a reputation for delivering steadiness and a lack of edginess, which helps drive repeat customers.
Genetic Lineage and Breeding Background
The precise genetic lineage of Zero Gravity (CBD) varies by producer, but it typically descends from established high-CBD parents. In many catalogs, breeders achieve a CBD-dominant chemotype by crossing lines such as ACDC, Harlequin, Candida (CD-1), or selections from the CBD Crew heritage. These parents are known for producing chemotypes with CBD levels routinely above 10% by dry weight and THC that often remains below 1–2%.
Given naming overlap in the industry, it is important to distinguish Zero Gravity (CBD) from similarly named THC-dominant strains. Some legacy breeders have used the Zero Gravity moniker for sedative, indica-leaning THC cultivars unrelated to the CBD expression. The CBD version is typically stabilized for a high-ratio CBD:THC profile and selected for bright, pine-herbal aromatics and moderate vigor.
Breeding goals for CBD-forward cultivars usually include: reliable CBD dominance across seed lots, improved terpene yield, and resistance to botrytis in dense flowers. Zero Gravity (CBD) selections follow this template, with growers reporting predictable ratios in properly stabilized lines. In well-selected populations, more than 80% of plants can meet the target CBD:THC ratio when seeds are sourced from a reputable breeder.
If sourcing genetics, growers should request historical COAs from the breeder that document multiple harvests and seasons. Look for ratio stability across different environments, not just one indoor run. Clonal propagation from a vetted mother remains the gold standard if you require uniform chemotype and growth habits.
Visual Appearance and Morphology
Zero Gravity (CBD) typically presents medium-density flowers with a calyx-forward structure and a solid calyx-to-leaf ratio. Buds often display lime to forest green hues, with peach to tangerine pistils that darken as they mature. Under dialed-in environments, the cultivar can show a frosted trichome layer, indicative of terpene retention and resin development.
Fans and sugar leaves are usually moderate in size, making late-veg defoliation straightforward. Side branching responds well to topping, which evens the canopy and reduces apical dominance. The internodal spacing is medium, giving enough airflow to limit microclimates that invite powdery mildew.
Outdoor and cool-night growers sometimes report anthocyanin expression, particularly near harvest if nighttime temperatures dip below 60°F (15.5°C). This can yield subtle violet tints at bract tips, though color expression is phenotype-dependent. Overall bag appeal is boosted by consistent trichome coverage, which also supports solventless extraction performance.
Average cola size ranges from 3–6 inches on indoor-trained plants, with larger colas possible under SCROG. The flowers trim relatively clean when dried properly, thanks to modest leaf wrappage around bracts. Visual uniformity improves markedly when plants are pruned to 6–12 strong tops per plant in a 5-gallon container.
Aroma: Nose Notes and Volatiles
The dominant aromatic impression of Zero Gravity (CBD) blends gentle pine, sweet herbs, and a peppery finish. Lighter top notes can include citrus zest, especially when limonene expresses in the upper quartile of the terpene profile. The base carries earth and wood, hinting at humulene and caryophyllene interplay.
With a careful dry and cure, pine-resin and green tea-like nuances become more apparent. Some batches lean more floral, suggesting a touch of linalool, while others lean savory and spicy. Storage conditions strongly influence this profile, as terpenes like myrcene and pinene are volatile and degrade with heat or oxygen exposure.
When assessed by typical industry gas chromatography methods, total terpene content in CBD-dominant flower often ranges between 0.8% and 2.5% by weight. Zero Gravity (CBD) frequently lands near the middle of that range when grown with optimal light intensity and a slow cure. Higher terpene yields correlate with cooler, slower drying and minimal rough handling after bucking.
Producers using living soil often report slightly more complex aromatics, likely due to a broader spectrum of secondary metabolites. Conversely, high EC and fast-dry protocols can flatten the aroma into a generic grassy profile. Targeting best practices in post-harvest handling typically preserves the nuanced pine-herbal signature.
Flavor and Mouthfeel
On the palate, Zero Gravity (CBD) mirrors its aroma with crisp pine and garden herbs up front. A mild sweetness emerges mid-draw, often compared to chamomile or green tea with a hint of citrus rind. The finish is clean and lightly peppery, leaving a dry, resinous echo without harshness when cured correctly.
Flavors tend to be more pronounced in vaporization compared to combustion, especially in the 350–380°F (177–193°C) range. At these temperatures, monoterpenes like alpha-pinene and limonene volatilize efficiently, allowing the pine-citrus layer to shine. Higher temperatures bring out caryophyllene’s pepper-clove dimension and a deeper wood tone.
Mouthfeel is smooth and moderately coating, reflecting a healthy trichome cap and balanced moisture content in the cured flower. Poor cures or over-drying can introduce a papery or hay-like note that mutes the pine and citrus. Keeping final jar RH between 55% and 62% preserves flavor fidelity over time.
Edible infusions derived from Zero Gravity (CBD) skew herbal and softly citrusy, pairing well with honey, ginger, or lemon. In tinctures, the profile is gentler, though decarboxylation can soften top notes. For solventless rosin, expect concentrated pine-spice with a subtle sweetness if harvested at peak terpene maturity.
Cannabinoid Profile and Potency Data
Zero Gravity (CBD) is positioned as a CBD-dominant cultivar, and its lab results typically reflect that emphasis. In well-grown, indoor conditions, CBD commonly measures between 10% and 18% by dry weight. THC is usually kept low, often 0.3% to 1.5%, though total THC can trend higher if harvest is delayed or if a variant chemotype is in play.
Ratios are a more intuitive way to view this cultivar. Many lots show CBD:THC ratios from 10:1 up to 20:1, with a central tendency around 12:1 to 15:1. This ratio is the main driver of its clear-headed, low-intoxication experience for most users.
Minor cannabinoids frequently detected include CBG at 0.5% to 1.5% and CBC around 0.2% to 0.8%. Total cannabinoid content often falls in the 14% to 20% range when summing all acids and neutrals. In extraction-bound material, preserving CBDA through careful harvest timing can boost total CBD post-decarboxylation.
Measurement variability is a real-world factor; inter-lab relative standard deviations of 5–15% are not uncommon for cannabinoids. Growers and buyers should rely on multiple COAs across batches to establish consistent potency baselines. Sampling across the canopy (top, middle, bottom colas) can reveal intra-plant variability of 10% or more if light distribution is uneven.
For consumers in hemp-regulated markets, confirm both delta-9 THC and total THC values remain compliant. Total THC is commonly calculated as THC + (0.877 × THCA), which captures decarboxylation potential. Harvesting a week earlier and optimizing cure temperatures can help maintain compliant totals when needed.
Terpene Profile and Chemistry
Terpene expression in Zero Gravity (CBD) often centers on myrcene, beta-caryophyllene, and alpha-pinene. In many lab reports, myrcene falls between 0.3% and 0.8%, lending earthy-sweet and herbal tones. Beta-caryophyllene frequently ranges 0.2% to 0.6%, contributing pepper and spice while interacting with CB2 receptors.
Alpha- and beta-pinene together can apply a fresh pine lift, commonly totaling 0.15% to 0.5%. Limonene, when present at 0.1% to 0.4%, adds a citrus brightness that reads as lemon zest or light orange. Supporting terpenes like humulene (0.1%–0.3%) and linalool (0.05%–0.2%) modulate the finish with woody and floral facets.
The overall terpene load of 1.0% to 2.0% is where many growers land with careful cultivation and curing. Values outside this range occur, but consistent mid-pack totals tend to correlate with the best flavor and perceived smoothness. Soil microbiome diversity, gentle handling, and low-temperature drying are reliable levers for increasing the terpene score.
From a functional chemistry perspective, the myrcene-caryophyllene-pinene triad offers a balanced experience. Myrcene may contribute to relaxation, while pinene is often associated with mental clarity, and caryophyllene may support anti-inflammatory pathways via CB2. The net effect is a grounded calm that feels breathable rather than sedating.
Experiential Effects and Functional Use
Zero Gravity (CBD) is engineered for even-keeled calm without heavy euphoria. Most users report a gentle lifting of mental noise within minutes when inhaled, followed by steady, non-drowsy relaxation. The experience is often described as unsticky—less inertia, more open headspace.
When vaporized or smoked, onset typically begins within 1–5 minutes, with peak effects around 15–30 minutes. Duration commonly spans 2–4 hours, with minimal aftereffects compared to THC-rich strains. Oral ingestion shifts the timeline to a 30–120 minute onset and a 4–8 hour duration, depending on dose and metabolism.
Functionally, many people use Zero Gravity (CBD) as a daytime companion for focus-intensive tasks or social situations. The low THC content reduces the likelihood of racing thoughts or short-term memory disruption compared to high-THC cultivars. The terpene profile, particularly pinene and limonene, supports an alert, gentle lift rather than sedation for most individuals.
Subjective reports often emphasize decreased bodily tension, easier breathing rhythms, and smoother conversation. For physically active users, it can serve as a post-training downshift that does not derail productivity. Music, light creative work, and low-stress meetings are common contexts where the strain shines.
As always, individual biochemistry matters, and effects can vary by tolerance, set, and setting. Those who are extremely THC-sensitive may still perceive a slight head change at higher inhaled doses. Starting low and going slow helps calibrate the experience to your specific needs.
Potential Medical and Wellness Applications
Zero Gravity (CBD) aligns with evidence-based use cases for cannabidiol while keeping THC exposure minimal. CBD has been studied for seizure disorders, with clinical trials of purified CBD showing median seizure reductions in the 37% to 42% range for specific pediatric epilepsies at prescribed doses. While flower is not a medical substitute for approved pharmaceuticals, high-CBD cultivars offer a whole-plant option valued for terpenes and minor cannabinoids.
Anxiety and stress modulation are frequent consumer-reported benefits with CBD-forward strains. Human studies have observed anxiolytic effects of acute CBD, particularly around performance anxiety, though results are dose- and context-dependent. In practical terms, many users report smoother social interactions and easier transitions between tasks when using Zero Gravity (CBD) in modest amounts.
Pain and inflammation are complex targets where CBD’s effects can be modest but meaningful for some. Preclinical data suggest anti-inflammatory activity via pathways such as NF-κB modulation and TRPV1, with human data showing mixed but promising signals for neuropathic pain. In real-world use, CBD-dominant flower is commonly used for minor musculoskeletal aches, recovery days, and joint discomfort.
Sleep outcomes depend on timing and dose. At daytime-appropriate amounts, Zero Gravity (CBD) often supports calm focus without sedation, but higher evening doses may promote sleep continuity for some users. Terpenes like myrcene and linalool can add a relaxing edge, though pinene and limonene may counterbalance with an alert feel earlier in the evening.
CBD also shows potential in supporting mood regulation and reducing cue-induced craving in some populations, though more robust, condition-specific research is needed. For inflammatory skin conditions, topical CBD has demonstrated favorable tolerability and potential benefits in early studies. Importantly, responses vary widely, and best outcomes occur with consistent routines and attention to product quality.
This discussion is for informational purposes and is not a substitute for professional medical advice. Individuals managing diagnosed conditions, taking prescription medications, or pregnant or breastfeeding should consult a qualified clinician before using cannabis. Always review a current certificate of analysis to confirm potency and contaminant testing.
Comprehensive Cultivation Guide
Zero Gravity (CBD) cultivates well in both indoor and outdoor settings, rewarding ca
